2018, Drug Development, Life Science and Patient Experience

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2018

Drug Development

Life Science

Patient Experience

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

.–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. It enables the delivery of traditional, hybrid and decentralised clinical trials while enhancing the patient experience.

Life Science

Life Science Digital Health Drug Development Patient Experience

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

NOVEMBER 14, 2022

In the past three years alone, the Company has grown exponentially, more than tripling its annual revenue, growing its employee base to 39, a 5x increase since 2018, and expanding its extensive client list to 125+ partners across the U.S. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.

Life Science

Life Science HIPAA Drug Development healthcare technology

Connected Health Pulse

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Stay Connected